Literature DB >> 12671062

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Kenneth W Tsang1, Pak L Ho, Gaik C Ooi, Wilson K Yee, Teresa Wang, Moira Chan-Yeung, Wah K Lam, Wing H Seto, Loretta Y Yam, Thomas M Cheung, Poon C Wong, Bing Lam, Mary S Ip, Jane Chan, Kwok Y Yuen, Kar N Lai.   

Abstract

BACKGROUND: Information on the clinical features of the severe acute respiratory syndrome (SARS) will be of value to physicians caring for patients suspected of having this disorder.
METHODS: We abstracted data on the clinical presentation and course of disease in 10 epidemiologically linked Chinese patients (5 men and 5 women 38 to 72 years old) in whom SARS was diagnosed between February 22, 2003, and March 22, 2003, at our hospitals in Hong Kong, China.
RESULTS: Exposure between the source patient and subsequent patients ranged from minimal to that between patient and health care provider. The incubation period ranged from 2 to 11 days. All patients presented with fever (temperature, >38 degrees C for over 24 hours), and most presented with rigor, dry cough, dyspnea, malaise, headache, and hypoxemia. Physical examination of the chest revealed crackles and percussion dullness. Lymphopenia was observed in nine patients, and most patients had mildly elevated aminotransferase levels but normal serum creatinine levels. Serial chest radiographs showed progressive air-space disease. Two patients died of progressive respiratory failure; histologic analysis of their lungs showed diffuse alveolar damage. There was no evidence of infection by Mycoplasma pneumoniae, Chlamydia pneumoniae, or Legionella pneumophila. All patients received corticosteroid and ribavirin therapy a mean (+/-SD) of 9.6+/-5.42 days after the onset of symptoms, and eight were treated earlier with a combination of beta-lactams and macrolide for 4+/-1.9 days, with no clinical or radiologic efficacy.
CONCLUSIONS: SARS appears to be infectious in origin. Fever followed by rapidly progressive respiratory compromise is the key complex of signs and symptoms from which the syndrome derives its name. The microbiologic origins of SARS remain unclear. Copyright 2003 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671062     DOI: 10.1056/NEJMoa030666

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  479 in total

Review 1.  SARS coronavirus: a new challenge for prevention and therapy.

Authors:  Kathryn V Holmes
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 2.  Antiviral treatment of SARS: can we draw any conclusions?

Authors:  Getu Zhaori
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

Review 3.  Severe acute respiratory syndrome and its lesions in digestive system.

Authors:  Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 4.  Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic.

Authors:  Roy M Anderson; Christophe Fraser; Azra C Ghani; Christl A Donnelly; Steven Riley; Neil M Ferguson; Gabriel M Leung; T H Lam; Anthony J Hedley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

5.  Confronting SARS: a view from Hong Kong.

Authors:  J S M Peiris; Y Guan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

Review 6.  Severe acute respiratory syndrome (SARS): epidemiology and clinical features.

Authors:  D S C Hui; M C H Chan; A K Wu; P C Ng
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

7.  Small molecules targeting severe acute respiratory syndrome human coronavirus.

Authors:  Chung-Yi Wu; Jia-Tsrong Jan; Shiou-Hwa Ma; Chih-Jung Kuo; Hsueh-Fen Juan; Yih-Shyun E Cheng; Hsien-Hua Hsu; Hsuan-Cheng Huang; Douglass Wu; Ashraf Brik; Fu-Sen Liang; Rai-Shung Liu; Jim-Min Fang; Shui-Tein Chen; Po-Huang Liang; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

8.  How did general practitioners protect themselves, their family, and staff during the SARS epidemic in Hong Kong?

Authors:  W C W Wong; A Lee; K K Tsang; S Y S Wong
Journal:  J Epidemiol Community Health       Date:  2004-03       Impact factor: 3.710

9.  Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.

Authors:  Paul B McCray; Lecia Pewe; Christine Wohlford-Lenane; Melissa Hickey; Lori Manzel; Lei Shi; Jason Netland; Hong Peng Jia; Carmen Halabi; Curt D Sigmund; David K Meyerholz; Patricia Kirby; Dwight C Look; Stanley Perlman
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  [Severe Acute Respiratory Syndrome. A new emergent infectious disease].

Authors:  Lluís Salleras
Journal:  Med Clin (Barc)       Date:  2003-05-03       Impact factor: 1.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.